Skip to main content
Caplight Logo









Elle, MD Biotechnologies

Elle, MD Biotechnologies

Private
Nova ScotiaHealthcare & Life Scienceshttps://ellemd.ca/

Last Round

Pre Seed

Jul 23, 2026

Total Funding Raised

$1.29M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Elle, MD Biotechnologies is a biotechnology company developing a novel, non-hormonal contraceptive device.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

non-hormonal contraceptivehormone-free birth controlvaginal ringcopper-based contraceptiveFemTechmedical devicewomen's healthreproductive healthIUD alternativeuser-controlled birth controlreusable contraceptivebiotechnologyemergency contraception

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Elle, MD Biotechnologies Comparables

Compare Elle, MD Biotechnologies with similar companies based on industry and business-model similarity.

Elle, MD Biotechnologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cirqle Biomedical
81%
3Daughters
77%
Hervana Bio
77%

Elle, MD Biotechnologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedJul 23, 2026
GrantNov 28, 2025
GrantNov 3, 2025
GrantOct 21, 2025
Pre SeedOct 14, 2025
SAFE
Jun 30, 2025

Key People

Founding team and executive leadership

Wendy Blanda

Acting Chief Technical Officer (CTO)

Executive Team

Catherine McGuire

Chief Operating Officer

Executive Team

Elle, MD Biotechnologies Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 461% MoM, reaching 2.3K.

  • Jul 23, 2026

    $803K raised from H Venture Partners and Innovacorp.

Elle, MD Biotechnologies Filings

Explore SEC and related filing metadata, where available.

Elle, MD Biotechnologies filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Elle, MD Biotechnologies's valuation, stock price, and market status.

Is Elle, MD Biotechnologies a public or private company?

Elle, MD Biotechnologies is a private company.

What is the current stock price of Elle, MD Biotechnologies?

Elle, MD Biotechnologies is a private company with no public stock price. No recent secondary market data is available.

How much is Elle, MD Biotechnologies worth (valuation)?

Valuation information for Elle, MD Biotechnologies is not publicly available.

Can I buy Elle, MD Biotechnologies stock?

Elle, MD Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Elle, MD Biotechnologies's last funding round?

Elle, MD Biotechnologies's most recent funding round was Grant on November 28, 2025.

Who are the main investors in Elle, MD Biotechnologies?

Key investors in Elle, MD Biotechnologies include Innovacorp, New Brunswick Innovation Foundation, Atlantic Canada Opportunities Agency, National Research Council Canada.

Will Elle, MD Biotechnologies IPO soon?

No public IPO plans have been announced for Elle, MD Biotechnologies.

How can I track Elle, MD Biotechnologies secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Elle, MD Biotechnologies's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNova Scotia
Employee Range7
Year Founded2022
Last FundingJul 23, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?